Artemis Medicare Services: Should You Buy, Hold, or Sell Right Now?
- September 8, 2026
- Posted by: Kunal Singla
- Category: Market
Artemis Medicare Services share price Rs 342.40 (NSE), near its 52-week high. 52-week range Rs 203.35 to Rs 344.60. Q1 FY27 profit up 48.3% YoY to Rs 31.44 crore.
Quick Answer
Artemis Medicare Services Ltd share price is trading around Rs 342, close to its 52-week high of Rs 344.60 and more than 68 percent above its 52-week low of Rs 203.35. Q1 FY27 revenue grew 11.7 percent year on year to Rs 292.69 crore, with net profit up 48.3 percent to Rs 31.44 crore from Rs 21.20 crore. Full-year FY26 revenue grew 14.6 percent with profit up 26.2 percent to Rs 103.72 crore from Rs 82.18 crore in FY25. The stock trades at 47.76 times earnings, a discount to the hospital and healthcare services sector average near 67.5 times.
Artemis Medicare Services share price is trading close to its 52-week high of Rs 344.60, with Artemis Medicare Services share price around Rs 342 on the NSE, more than 68 percent above its 52-week low of Rs 203.35. With strong, consistent growth continuing in Q1 FY27, investors are asking whether this hospital operator is a stock to buy near its highs, a hold, or a sell.
This Artemis Medicare Services stock analysis walks through the Q1 FY27 numbers, valuation against the hospital and healthcare services sector, shareholding pattern and the technical setup, using figures sourced from public filings.
Click Here – Get Free Investment Predictions
About Artemis Medicare Services
Before deciding on Artemis Medicare Services share price, it helps to understand the underlying business. Artemis Medicare Services Ltd. operates hospital and healthcare services, with its flagship facility located in Gurugram, serving patients with multi-speciality medical care.
As a hospital operator, Artemis Medicare Services has delivered strong, consistent growth across recent periods, with profit growth outpacing revenue growth, reflecting improving operational efficiency and case mix.
Artemis Medicare Services Share Price Today: Key Levels
The table below summarises where Artemis Medicare Services share price stands right now against its recent trading range and market value.
| Metric | Value |
|---|---|
| Artemis Medicare Services CMP (NSE) | Rs 342.40 |
| Artemis Medicare Services CMP (BSE) | Rs 343.65 |
| 52-Week High | Rs 344.60 |
| 52-Week Low | Rs 203.35 |
| Market Capitalisation | Approximately Rs 5,443 crore |
| Dividend Yield | 0.13% |
Artemis Medicare Services share price is trading close to its 52-week high, having risen more than 68 percent from its 52-week low, reflecting strong investor confidence in the company’s consistent growth.
Check the Univest Screener for Live Stock Data
Artemis Medicare Services Financial Performance
The Artemis Medicare Services share price trend is closely tied to how these numbers evolve each quarter. Artemis Medicare Services reported Q1 FY27 (June 2026 quarter) revenue of Rs 292.69 crore, up 11.7 percent year on year from Rs 261.89 crore, with net profit growing 48.3 percent year on year to Rs 31.44 crore from Rs 21.20 crore, continuing a consistent growth trend across recent quarters.
For the full year FY26, the company reported revenue of Rs 1,111.07 crore, up 14.6 percent year on year, with net profit of Rs 103.72 crore, up 26.2 percent from Rs 82.18 crore in FY25, confirming the growth trend has been sustained across the full year.
| Period | Revenue | Net Profit | Comment |
|---|---|---|---|
| Q1 FY27 (Jun 2026) | Rs 292.69 crore | Rs 31.44 crore | +11.7% revenue, +48.3% profit YoY |
| FY26 (full year) | Rs 1,111.07 crore | Rs 103.72 crore | +14.6% revenue, +26.2% profit YoY |
Valuation Check: Is Artemis Medicare Services Share Price Expensive?
Any view on Artemis Medicare Services share price should start from these valuation multiples. Artemis Medicare Services share price currently reflects a price to earnings ratio of about 47.76 times trailing earnings, a discount to the broader hospital and healthcare services sector average of roughly 67.5 times. The price to book ratio stands near 6.3 times, supported by an 11.09 percent return on equity.
Debt to equity of 0.28 is low. Given the strong, consistent growth delivered across recent periods, with profit growth outpacing revenue growth, this discount valuation could offer room for re-rating if the growth trend continues.
Technical Signals: What the Chart Shows
Price action here often foreshadows the next move in Artemis Medicare Services share price. Artemis Medicare Services share price is currently positioned just below its 52-week high of Rs 344.60, more than 68 percent above its 52-week low of Rs 203.35, reflecting a very strong overall run over the past year. A stock trading this close to its high, backed by consistent strong growth, typically signals the market rewarding tangible execution in the hospital’s operations.
Trading volumes remain heavy, so investors should track Artemis Medicare Services share price alongside continued occupancy and case mix trends in coming quarters, rather than reacting to any single day’s move at these technical levels.
Download the Univest iOS App or Univest Android App to track Artemis Medicare Services’ live price and technical levels.
Shareholding Pattern
Shifts here can influence Artemis Medicare Services share price more than headline news on some sessions. Artemis Medicare Services is a promoter-led hospital and healthcare services operator with low leverage. A detailed current promoter, FII and DII percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company’s latest exchange filing.
Why Investors Are Watching Artemis Medicare Services
- Strong and consistent growth: Both Q1 FY27 and full FY26 showed strong revenue growth with even stronger profit growth, a consistent trend across recent periods.
- Discount valuation to sector: A 47.76x PE against a 67.5x hospital and healthcare services sector average offers meaningful valuation cushion given the strong growth.
- Low financial leverage: A debt to equity ratio of just 0.28 gives the company financial flexibility to fund continued growth.
- Strong stock performance over the past year: The stock has risen more than 68 percent from its 52-week low, reflecting sustained investor confidence.
Risks and Factors to Watch
- Rich absolute valuation despite the sector discount: A 47.76x PE remains elevated in absolute terms, and continued strong execution is needed to justify this level even at a discount to the broader sector.
- Healthcare services sector competitive pressure: Artemis Medicare Services competes against other hospital chains and healthcare providers, particularly in the Delhi NCR region.
- Regulatory and pricing pressure in healthcare: As a hospital operator, the company faces exposure to healthcare pricing regulations and reimbursement policy changes.
- Single-facility concentration: With its flagship facility concentrated in Gurugram, the company’s fortunes are closely tied to that specific market’s healthcare demand.
Artemis Medicare Services Share Price Target: What the Data Suggests
Until then, Artemis Medicare Services share price remains best tracked through live, verified data rather than a single fixed number. Artemis Medicare Services does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. What the data shows is a company delivering strong, consistent growth, trading at a discount to the hospital and healthcare services sector.
Investors who want live, updated research can check the Univest Screener, and should consult a SEBI-registered investment adviser for guidance tailored to their own goals.
Artemis Medicare Services: Should You Buy, Hold, or Sell Right Now?
This is the core question behind Artemis Medicare Services share price right now. The Artemis Medicare Services buy or sell decision depends on whether you value this consistent execution at the current level.
The case for buying: Investors who believe in Artemis Medicare Services’ hospital operations and see the discount to sector PE as attractive may find the current level, near its 52-week high, reasonable given the growth delivered.
The case for holding: Existing shareholders who already track Artemis Medicare Services’ growth trajectory may prefer to stay invested.
The case for waiting: Investors wanting a larger valuation cushion before committing fresh capital may prefer to wait for a more attractive entry point.
Historically, hospital operators with strong, consistent execution have rewarded patient investors, so weigh this against your own risk tolerance and consult a SEBI-registered investment adviser if unsure.
Conclusion
Artemis Medicare Services share price reflects a hospital operator delivering strong, consistent growth in Q1 FY27 and full FY26, trading close to its 52-week high at a discount to the hospital and healthcare services sector. This article is for informational purposes and not a personalised investment recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Q1. Is Artemis Medicare Services a good stock to buy right now?
Ans. Artemis Medicare Services grew Q1 FY27 profit 48.3 percent year on year, continuing a strong trend also seen in FY26’s 26.2 percent annual profit growth. The stock trades at a discount to the hospital and healthcare services sector, though it remains rich in absolute terms.
Q2. What is the Artemis Medicare Services share price today?
Ans. Artemis Medicare Services share price is trading around Rs 342 on the NSE, close to its 52-week high of Rs 344.60. The stock’s 52-week low is Rs 203.35.
Q3. What is the Artemis Medicare Services share price target?
Ans. Artemis Medicare Services does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. Investors can check live research on the Univest Screener and consult a SEBI-registered adviser.
Q4. What does Artemis Medicare Services do?
Ans. Artemis Medicare Services operates hospital and healthcare services, with its flagship facility located in Gurugram, serving patients with multi-speciality medical care.
Q5. What is Artemis Medicare Services’ market capitalisation and PE ratio?
Ans. Artemis Medicare Services has a market capitalisation of approximately Rs 5,443 crore and trades at a price to earnings ratio of about 47.76 times, a discount to the hospital and healthcare services sector average PE of roughly 67.5 times.
Q6. Where is Artemis Medicare Services’ hospital located?
Ans. Artemis Medicare Services’ flagship hospital facility is located in Gurugram, serving patients with multi-speciality medical care.
